Psychosocial consequences of potential overdiagnosis in prostate cancer a qualitative interview study
Background Prostate cancer is a frequently diagnosed cancer and made up 6% of male cancer deaths globally in 2008. Its incidence varies more than 25-fold worldwide, which is primarily attributed to the implementation of the prostate-specific antigen (PSA) test in developed countries. To reduce harm...
Main Authors: | Sigrid Brisson Nielsen, Olivia Spalletta, Mads Aage Toft Kristensen, John Brodersen |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-10-01
|
Series: | Scandinavian Journal of Primary Health Care |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/02813432.2020.1843826 |
Similar Items
-
Free prostate-specific antigen outperforms total prostate-specific antigen as a predictor of prostate volume in patients without prostate cancer
by: Sinan Avci, et al.
Published: (2020-04-01) -
Prostate-specific antigen velocity in diagnosis and prognosis of prostate cancer - a systematic review
by: Arslaan Javaeed, et al.
Published: (2020-05-01) -
Elevated prostate volume index and prostatic chronic inflammation reduce the number of positive cores at first prostate biopsy set: results in 945 consecutive patients
by: Antonio B. Porcaro, et al. -
The Value of Prostate-Specific Antigen-Related Indexes and Imaging Screening in the Diagnosis of Prostate Cancer
by: Bai X, et al.
Published: (2020-08-01) -
Analysis of the Correlationship between Prostate Specific Antigen Related Variables and Risk Factor in Patients with Prostate Carcinoma
by: Daoyuan Wang, et al.
Published: (2015-01-01)